Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Accumulated Expenses: 2015-2025

Historic Accumulated Expenses for HUTCHMED (China) (HCM) over the last 11 years, with Jun 2025 value amounting to $20.4 million.

  • HUTCHMED (China)'s Accumulated Expenses fell 22.36% to $20.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $20.4 million, marking a year-over-year decrease of 22.36%. This contributed to the annual value of $29.8 million for FY2024, which is 33.96% down from last year.
  • As of Q2 2025, HUTCHMED (China)'s Accumulated Expenses stood at $20.4 million, which was down 31.50% from $29.8 million recorded in Q4 2024.
  • HUTCHMED (China)'s Accumulated Expenses' 5-year high stood at $45.0 million during Q4 2023, with a 5-year trough of $12.9 million in Q1 2021.
  • Over the past 3 years, HUTCHMED (China)'s median Accumulated Expenses value was $28.0 million (recorded in 2024), while the average stood at $30.4 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 90.09% in 2021, then crashed by 33.96% in 2024.
  • MRQ analysis of 5 years shows HUTCHMED (China)'s Accumulated Expenses stood at $41.8 million in 2021, then increased by 1.57% to $42.4 million in 2022, then rose by 6.14% to $45.0 million in 2023, then plummeted by 33.96% to $29.8 million in 2024, then crashed by 31.50% to $20.4 million in 2025.
  • Its last three reported values are $20.4 million in Q2 2025, $29.8 million for Q4 2024, and $26.2 million during Q2 2024.